Stay updated with breaking news from Nasdaq Eldn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) had its target price cut by HC Wainwright from $25.00 to $13.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.31) EPS. A number of other research firms […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) saw a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 36,300 shares, a decrease of 85.1% from the June 15th total of 244,200 shares. Based on an average daily trading volume, of 198,000 shares, the days-to-cover […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – HC Wainwright issued their Q2 2023 EPS estimates for Eledon Pharmaceuticals in a research report issued to clients and investors on Friday, May 26th. HC Wainwright analyst V. Bernardino anticipates that the company will earn ($0.47) per share for the quarter. The consensus estimate for Eledon Pharmaceuticals’ […]
Cantor Fitzgerald reissued their overweight rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) in a report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Eledon Pharmaceuticals’ FY2023 earnings at ($1.83) EPS. Eledon Pharmaceuticals Stock Down 0.4 % Shares of NASDAQ:ELDN opened at $2.24 on Monday. The stock has a […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 57,200 shares, a growth of 276.3% from the April 15th total of 15,200 shares. Currently, 0.4% of the shares of the company are sold short. Based on […]